The WACC of NGM Biopharmaceuticals Inc (NGM) is 6.0%.
| Range | Selected | |
| Cost of equity | 6.50% - 10.20% | 8.35% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.1% - 6.9% | 6.0% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.58 | 0.95 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.50% | 10.20% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.1% | 6.9% |
| Selected WACC | 6.0% | |